You're tuned in to Tech Beat, your daily read on the stories shaping our digital world.
Eli Lilly's experimental drug retatrutide is turning heads in the medical community. Two Phase three clinical trials involving more than one thousand adults show the GLP-one based treatment delivers significant knee osteoarthritis pain relief alongside dramatic weight loss, strengthening its case for FDA approval on both fronts simultaneously.
Shifting to the world of music, AI-generated songs are quietly flooding Spotify and other streaming platforms, and most listeners have no idea. Researchers and critics say there are telltale signs in the vocals, lyrics, and instrumentation, but catching them requires a trained ear that most of us simply haven't developed yet.
And in the world of software development, the team behind the AI coding platform Lovable has shared a candid post-mortem after processing one hundred thousand pull requests. Their headline lesson was striking: they deleted nearly all of their agent code and started over, arguing that simplicity consistently outperformed complexity in production environments.
Those are today's top stories. Keep surfing. Tech Beat out.
